Home › Trials › NCT05788666
Clinical trial Recruiting at 1 site Interventional Ages 75 to 100

Using GeriKit to assess older adults with heart disease

Official title: Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease

Run by NYU Langone Health · NCT05788666 · Data updated 2026-11-12

This study is testing a mobile app called GeriKit to see if it can help doctors better understand and assess older adults with heart disease.

Quick facts

Study typeInterventional
Ages75 Years to 100 Years
SexAll
Enrollment150 (estimated)
SponsorNYU Langone Health
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedJanuary 18, 2024
Main results expectedMarch 1, 2027
Study endsDecember 31, 2027
Registry record updatedNovember 2, 2026
Trial IDNCT05788666 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are older adults aged 75 and above who are currently hospitalized for acute myocardial infarction, percutaneous coronary intervention, or coronary artery bypass grafting.

Probably not a fit

Patients who are non-ambulatory or have moderate to severe cognitive impairment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to utilize the NYU GeriKit mobile application to better phenotype older patients with ischemic heart disease. It is a single-center proof of concept study conducted at NYU Langone Medical Center, focusing on geriatric impairments and feasibility metrics. The GeriKit app is designed to make geriatric assessment tools accessible to clinicians without specialized geriatrics training, and while it has been used clinically, this study will explore its application in a research context.

Why it matters

Potential benefit: If successful, this approach could improve the assessment and management of older adults with ischemic heart disease, leading to better patient outcomes.

How similar studies have gone: While the GeriKit app has been used in clinical settings, this specific application in a research context is novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

1. Age ≥ 75
2. Currently hospitalized for acute mycardial infarction (AMI), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG); or hospitalized for AMI, PCI, or CABG within the prior 4 weeks
3. Capable of self-consent
4. Understand and are able to perform study procedures in English

Exclusion Criteria:

1. Non-ambulatory
2. Moderate or severe cognitive impairment (operationalized as known diagnosis of dementia)
3. Unable or unwilling to consent
4. Incarcerated
5. Unable to use complete assessments in English
6. Unable to complete geriatric assessment for other reasons

Where it's running

  • NYU Langone Health
    New York, New York, United States     Recruiting

Study contacts

  • Principal investigator: John A. Dodson, MD, MPH, FACC — NYU Langone Health
  • Study coordinator: John A. Dodson, MD, MPH, FACC
  • Email: Cdhlab@nyulangone.org
  • Phone: (646) 501-2714

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Ischemic Heart Disease 59NYU Langone Health 183
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.